Efficacy and Safety of a Novel Nicotinamide Modified-Release Formulation in the Treatment of Refractory Hyperphosphatemia in Patients Receiving Hemodialysis—A Randomized Clinical Trial

INTRODUCTION: Despite widespread use of phosphate binders (PBs), phosphate control is insufficient in many hemodialysis patients. Preliminary clinical observations suggest that nicotinamide may act synergistically with PBs to improve phosphate control. METHODS: This multinational, randomized, double...

Descripción completa

Detalles Bibliográficos
Autores principales: Ketteler, Markus, Wiecek, Andrzej, Rosenkranz, Alexander R., Pasch, Andreas, Rekowski, Jan, Hellmann, Burkhard, Karus, Michael, Ammer, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938065/
https://www.ncbi.nlm.nih.gov/pubmed/33732974
http://dx.doi.org/10.1016/j.ekir.2020.12.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938065/
https://www.ncbi.nlm.nih.gov/pubmed/33732974
http://dx.doi.org/10.1016/j.ekir.2020.12.012

Ejemplares similares